 |
 |
 |
| AstraZeneca Jobs Profile This profile is a brief introduction for people seeking employment in pharmaceutical graduate jobs, pharmaceutical nurse advisors, pharmaceutical sales jobs, pharmaceutical training jobs, pharmaceutical sales management jobs, pharmaceutical marketing jobs, pharmaceutical executive jobs, or pharmaceutical clinical research associates who may be considering working for AstraZeneca UK Limited. Company Overview Astra Zeneca, the UK's second biggest home grown "big pharma" company has continued to thrive over the last few years, despite some serious setbacks to its late - stage pipeline. Disappointments over first-in-class drug Exanta and Iressa have depleted the company's future prospects but worldwide sales rose 12% to $11.8 billion in the first half of 2005, with operating profit surging 44% in the same period. UK sales have been hit in recent years, however, and in 2004 the company slid to fifth in overall sales from number three in 2000. UK sales have suffered since the patent expiry of Losec and a subsequent lack of enthusiasm for Nexium and statin Crestor, despite stronger update in other markets for these products. But strong growth in a number of other products, most notably anti- psychotic Seroquel and breast cancer drug Arimidex mean the company's future remains bright. The company employs nearly 12,000 people in its R&D operations in England and Sweden. In the UK, Astra Zeneca employs around 10,200 in total with around 7,500 based in Cheshire, with UK headquarters and marketing offices based at Horizon Place near Luton. The company was ranked among the most respected pharma employers in a recent Science magazine survey.
|
 Current Jobs Integrated Healthcare Specialist Location: East Midlands Integrated Healthcare Specialist Location: West Midlands North News AstraZeneca to sponsor mental health research AstraZeneca is sponsoring a new project to put recovery at the heart of the mental health agenda. The scheme is in partnership with MDF The BiPolar Organisation and Rethink - two mental health chariti... AstraZeneca: Seroquel a key part of company portfolio AstraZeneca has reiterated the importance of Seroquel (quetiapine fumarate) following the granting of summary judgement for patent litigation for the drug. AstraZeneca loses biologistics chief AstraZeneca has seen its chief of biologistics make clear his intention to leave the company at the end of this month. AstraZeneca announces management changes The president and chief executive officer at AstraZeneca's biologics business unit has announced he is leaving the company in the end of July. AstraZeneca signs diabetes and obesity agreement AstraZeneca has announced that it has signed a strategic research collaboration with Columbia University Medical Centre for the development of innovative treatments for obesity and type 2 diabetes. | ||||||||
